# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791

> **NCT02370043** · PHASE1 · COMPLETED · sponsor: **Kaneq Bioscience Limited** · enrollment: 19 (actual)

## Conditions studied

- Healthy Volunteers
- Insulin Resistance

## Interventions

- **DRUG:** KQ-791
- **DRUG:** KQ-791 (after meal)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02370043
- **Lead sponsor:** Kaneq Bioscience Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370043, "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02370043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*